While FDA-approved CAR T-cell therapies targeting B-cell maturation antigen (BCMA) exist for treating relapsed and refractory multiple myeloma, Indian patients lack access due to prohibitive costs and limited availability., While FDA-approved CAR T-cell therapies targeting B-cell maturation antigen (BCMA) exist for treating relapsed and refractory multiple myeloma, Indian patients lack access due to prohibitive costs and limited availability., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way